$HAE News

Last published 1d ago

1d agoOBIO HAE MDTOrchestra BioMed Reports Third Quarter 2026 Financial Results and Highlights Recent Business UpdatesGlobeNewswire
6d agoHAEQ2 2027 Haemonetics Corporation Earnings Conference Call - HAEMONETICS CORPEarnings Call TranscriptsHello, and welcome to Hemonetics Corporation's second quarter 2027 earnings conference call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there will be a question and answer
6d agoHAEHAEMONETICS CORP - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
3w agoZION CCK FNB HAE+1Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50-Day LinePR NewswireVANCOUVER, BC, Oct. 19, 2026 /CNW/ -- Stock Preachers News Commentary - Big tech drove a sharp rebound into the close, with the Nasdaq Composite up 1.11% and the S&P 500 up 0.66% on the session, while the Dow Jones
3w agoHAEHaemonetics Announces FDA Approval of PerQseal® Elite Vascular Closure SystemPR NewswireBOSTON, Oct. 19, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced U.S. Food
1mo agoHAEHaemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026PR NewswireHaemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2027 financial results at 6:00 am ET on...
1mo agoOBIO HAEOrchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by HaemoneticsGlobeNewswirePayment follows approximately $5 million received in January 2026, bringing total cash proceeds received to approximately $11 millionCompany remains eligible for up to approximately $10 million in additional proceeds
2mo agoAZTA CG HAEAZENTA ANNOUNCES LEADERSHIP TRANSITIONPR NewswireAzenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. Martin Madaus ...
3mo agoHAEQ1 2027 Haemonetics Corporation Earnings Conference Call - HAEMONETICS CORPEarnings Call TranscriptsGood day, and thank you for standing by. Welcome to the Humanitics Corporation First Quarter 2027 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, ther
3mo agoHAEHaemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations WebsitePR NewswireHaemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2027, which ended June 27, 2026, are available ...
3mo agoHAENew Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore SheathsPR NewswireHaemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient...
3mo agoHAEMartin Madaus Elected to Haemonetics Board of DirectorsPR NewswireHaemonetics Corporation (NYSE: HAE) a global medical technology company focused on delivering innovative medical solutions to drive better patient...
4mo agoHAEHaemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026PR NewswireHaemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2027 financial results at 6:00 am ET on...
5mo agoHAEHaemonetics Updates Financial Reporting SegmentsPR NewswireHaemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient...
5mo agoHAEHaemonetics to Present at Goldman Sachs 47th Annual Global Healthcare ConferencePR NewswireHaemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman...
6mo agoHAEQ4 2026 Haemonetics Corporation Earnings Conference Call - HAEMONETICS CORPEarnings Call TranscriptsHello and welcome to the Q4 2026 Hemonetics Corporations Earnings Conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session.
6mo agoHAEHaemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations WebsitePR NewswireHaemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal year 2026, which ended March 28, 2026, are...
6mo agoHAEHaemonetics to Present at Bank of America 2026 Healthcare ConferencePR NewswireHaemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Bank of...
6mo agoHAENew Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure ProceduresPR NewswireHaemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient...
7mo agoHAEHaemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026PR NewswireHaemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter fiscal year 2026 financial results at 6:00 am ET on...
7mo agoHAEHaemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure SystemPR NewswireHaemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient...
8mo agoHAEHaemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS TechnologyPR NewswireHaemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient...
8mo agoHAEHaemonetics to Present at Raymond James 47th Annual Institutional Investors ConferencePR NewswireHaemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond...
9mo agoHAEHaemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations WebsitePR NewswireHaemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2026, which ended December 27, 2025, are...
10mo agoHAE OBIOOrchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by HaemoneticsGlobeNewswire$11 million in proceeds expected to be received during 2026, with remainder of expected proceeds to be received in future revenue earnoutsVivasure Medical Limited ("Vivasure") has been a strategic holding of Orchestra
10mo agoHAEEQT Life Sciences to exit Vivasure Medical via sale to HaemoneticsPR NewswireEQT Life Sciences is pleased to announce that the LSP Health Economics Fund has exited Vivasure Medical Limited ("Vivasure" or the "Company"), a...
10mo agoHAEHaemonetics Acquires Vivasure Medical LimitedPR NewswireHaemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient...
10mo agoHAEHaemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026PR NewswireHaemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2026 financial results at 6:00 am ET on...
10mo agoHAEHaemonetics to Present at 44th Annual J.P. Morgan Healthcare ConferencePR NewswireHaemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference...
1y agoHAEHaemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations WebsitePR NewswireHaemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2026, which ended September 27, 2025, are...
1y agoHAEHaemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025PR NewswireHaemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2026 financial results at 6:00 am ET on...
1y agoHAEHaemonetics Corporation (HAE) Q1 2026 Earnings Call TranscriptEarnings Call Transcripts
1y agoHAEHaemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations WebsitePR NewswireHaemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2026, which ended June 28, 2025, are available ...
1y agoHAEHaemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025PR NewswireHaemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2026 financial results at 6:00 am ET on...
1y agoHAE OBIOVivasure Medical Submits PMA Application for PerQseal® Elite and Secures Expanded Venous Indication in EuropeBusiness WireRegulatory progress underscores global momentum for PerQseal Elite in transforming large-bore vascular closure Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel
1y agoHAEHaemonetics to Present at Goldman Sachs 46th Annual Global Healthcare ConferencePR NewswireHaemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman...
1y agoHAEHaemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations WebsitePR NewswireHaemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year 2025, which ended March 29, 2025, are...
1y agoHAE OBIOVivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure SystemBusiness WireFirst fully absorbable, sutureless closure system designed for large-bore procedures aims to improve procedural efficiency and patient outcomes in structural heart interventions Vivasure Medical®, a company
1y agoHAEHaemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025PR NewswireHaemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2025 financial results at 6:00 am ET ...
1y agoHAEHaemonetics Announces Executive Leadership UpdatesPR NewswireHaemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient...
1y agoHAEHaemonetics to Present at Raymond James 46th Annual Institutional Investors ConferencePR NewswireHaemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond...
1y agoHAEHaemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations WebsitePR NewswireHaemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2025, which ended December 28, 2024, are...
1y agoHAEHaemonetics Completes Sale of Whole Blood Assets to GVS, S.p.APR NewswireHaemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient...
1y agoHAEHaemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025PR NewswireHaemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2025 financial results at 6:00 am ET on...
1y agoHAEHaemonetics to Present at 43rd Annual J.P. Morgan Healthcare ConferencePR NewswireHaemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference...
1y agoHAEHaemonetics Announces Sale of Whole Blood Assets to GVS, S.p.APR NewswireHaemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient...
1y agoHAE MDT OBIOOrchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business UpdateGlobeNewswireNEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company")), a biomedical innovation company accelerating high-impact technologies to patients
2y agoHAEHaemonetics Corporation (HAE) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
2y agoHAEHaemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations WebsitePR NewswireHaemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2025, which ended September 28, 2024, are...
2y agoHAEHaemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024PR NewswireHaemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2025 financial results at 6:00 am ET on...